review · 1998
Design and interpretation of clinical trials that evaluate agents that may offer protection from the toxic effects of cancer chemotherapy.
RCTs have shown clear evidence of biologic activity for the protective agents, but this does not imply therapeutic benefit as compared with alternative strat...
42 citationsDOI: https://doi.org/10.1200/jco.1998.16.9.3179